Vertex to acquire ViaCyte for $320 million
PEGreviews
07/12/2022
On July 11, Vertex announced that it had reached an agreement with ViaCyte to acquire the latter for $320 million, with the aim of accelerating
Tag: cell therapies
Recent Articles
What is APN Linkers？
03/13/2023
The role of folic acid in targeted drugs
03/08/2023
What is Cleavable linkers?
02/20/2023
